1. Wu, Qiming, Tsuduki, Tsuyoshi. . CYP4F13 is the Major Enzyme for Conversion of alpha-Eleostearic Acid into cis-9, trans-11-Conjugated Linoleic Acid in Mouse Hepatic Microsomes. In Journal of oleo science, 69, 1061-1075. doi:10.5650/jos.ess20080. https://pubmed.ncbi.nlm.nih.gov/32879197/
2. Han, Juying, Robinet, Peggy, Ritchey, Brian, Andro, Heather, Smith, Jonathan D. 2019. Confirmation of Ath26 locus on chromosome 17 and identification of Cyp4f13 as an atherosclerosis modifying gene. In Atherosclerosis, 286, 71-78. doi:10.1016/j.atherosclerosis.2019.05.007. https://pubmed.ncbi.nlm.nih.gov/31102955/
3. Zhang, Guomei, Zhou, Xuming, Liu, Shanshan, Cao, Zhaoyun, Sun, Lihua. 2024. Full-length transcriptomics study of Ustiloxins-induced hepatocyte injury. In Toxicon : official journal of the International Society on Toxinology, 238, 107604. doi:10.1016/j.toxicon.2024.107604. https://pubmed.ncbi.nlm.nih.gov/38181838/
4. Du, Liping, Yin, Huiyong, Morrow, Jason D, Strobel, Henry W, Keeney, Diane S. 2009. 20-Hydroxylation is the CYP-dependent and retinoid-inducible leukotriene B4 inactivation pathway in human and mouse skin cells. In Archives of biochemistry and biophysics, 484, 80-6. doi:10.1016/j.abb.2009.01.012. https://pubmed.ncbi.nlm.nih.gov/19467632/
5. El-Ghiaty, Mahmoud A, Alqahtani, Mohammed A, El-Mahrouk, Sara R, Alammari, Ahmad H, El-Kadi, Ayman O S. 2024. Alteration of Hepatic Cytochrome P450 Expression and Arachidonic Acid Metabolism by Arsenic Trioxide (ATO) in C57BL/6 Mice. In Biological trace element research, 203, 1000-1015. doi:10.1007/s12011-024-04225-1. https://pubmed.ncbi.nlm.nih.gov/38758479/
6. Liu, Yunlong, Balaraman, Yokesh, Wang, Guohua, Nephew, Kenneth P, Zhou, Feng C. . Alcohol exposure alters DNA methylation profiles in mouse embryos at early neurulation. In Epigenetics, 4, 500-11. doi:. https://pubmed.ncbi.nlm.nih.gov/20009564/
7. Elshenawy, Osama H, Anwar-Mohamed, Anwar, Abdelhamid, Ghada, El-Kadi, Ayman O S. 2012. Murine atrial HL-1 cell line is a reliable model to study drug metabolizing enzymes in the heart. In Vascular pharmacology, 58, 326-33. doi:10.1016/j.vph.2012.12.002. https://pubmed.ncbi.nlm.nih.gov/23268359/
8. Gai, Zhibo, Gui, Ting, Alecu, Irina, Hausler, Stephanie, Kullak-Ublick, Gerd A. 2020. Farnesoid X receptor activation induces the degradation of hepatotoxic 1-deoxysphingolipids in non-alcoholic fatty liver disease. In Liver international : official journal of the International Association for the Study of the Liver, 40, 844-859. doi:10.1111/liv.14340. https://pubmed.ncbi.nlm.nih.gov/31883408/
9. Theken, Katherine N, Deng, Yangmei, Kannon, M Alison, Poloyac, Samuel M, Lee, Craig R. 2010. Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism. In Drug metabolism and disposition: the biological fate of chemicals, 39, 22-9. doi:10.1124/dmd.110.035287. https://pubmed.ncbi.nlm.nih.gov/20947618/
10. Amara, Issa E A, Elshenawy, Osama H, Abdelrady, Mohamed, El-Kadi, Ayman O S. 2014. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart. In Toxicology letters, 226, 53-62. doi:10.1016/j.toxlet.2014.01.025. https://pubmed.ncbi.nlm.nih.gov/24472606/